323 related articles for article (PubMed ID: 18832086)
1. Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat.
Cummings BP; Digitale EK; Stanhope KL; Graham JL; Baskin DG; Reed BJ; Sweet IR; Griffen SC; Havel PJ
Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1782-93. PubMed ID: 18832086
[TBL] [Abstract][Full Text] [Related]
2. Dietary fructose accelerates the development of diabetes in UCD-T2DM rats: amelioration by the antioxidant, alpha-lipoic acid.
Cummings BP; Stanhope KL; Graham JL; Evans JL; Baskin DG; Griffen SC; Havel PJ
Am J Physiol Regul Integr Comp Physiol; 2010 May; 298(5):R1343-50. PubMed ID: 20147607
[TBL] [Abstract][Full Text] [Related]
3. Novel canine models of obese prediabetes and mild type 2 diabetes.
Ionut V; Liu H; Mooradian V; Castro AV; Kabir M; Stefanovski D; Zheng D; Kirkman EL; Bergman RN
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E38-48. PubMed ID: 19843874
[TBL] [Abstract][Full Text] [Related]
4. Deterioration of plasticity and metabolic homeostasis in the brain of the UCD-T2DM rat model of naturally occurring type-2 diabetes.
Agrawal R; Zhuang Y; Cummings BP; Stanhope KL; Graham JL; Havel PJ; Gomez-Pinilla F
Biochim Biophys Acta; 2014 Sep; 1842(9):1313-23. PubMed ID: 24840661
[TBL] [Abstract][Full Text] [Related]
5. Diabetes in Zucker diabetic fatty rat.
Shiota M; Printz RL
Methods Mol Biol; 2012; 933():103-23. PubMed ID: 22893404
[TBL] [Abstract][Full Text] [Related]
6. Effect of periodontitis on insulin resistance and the onset of type 2 diabetes mellitus in Zucker diabetic fatty rats.
Watanabe K; Petro BJ; Shlimon AE; Unterman TG
J Periodontol; 2008 Jul; 79(7):1208-16. PubMed ID: 18597603
[TBL] [Abstract][Full Text] [Related]
7. Rare sugar D-psicose prevents progression and development of diabetes in T2DM model Otsuka Long-Evans Tokushima Fatty rats.
Hossain A; Yamaguchi F; Hirose K; Matsunaga T; Sui L; Hirata Y; Noguchi C; Katagi A; Kamitori K; Dong Y; Tsukamoto I; Tokuda M
Drug Des Devel Ther; 2015; 9():525-35. PubMed ID: 25632221
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic Fat is not significantly correlated with β-cell Dysfunction in Patients with new-onset Type 2 Diabetes Mellitus using quantitative Computed Tomography.
Li YX; Sang YQ; Sun Y; Liu XK; Geng HF; Zha M; Wang B; Teng F; Sun HJ; Wang Y; Qiu QQ; Zang X; Wang Y; Wu TT; Jones PM; Liang J; Xu W
Int J Med Sci; 2020; 17(12):1673-1682. PubMed ID: 32714070
[No Abstract] [Full Text] [Related]
9. Lipid accumulation in overweight type 2 diabetic subjects: relationships with insulin sensitivity and adipokines.
Sambataro M; Perseghin G; Lattuada G; Beltramello G; Luzi L; Pacini G
Acta Diabetol; 2013 Jun; 50(3):301-7. PubMed ID: 22215127
[TBL] [Abstract][Full Text] [Related]
10. TAK-875, a GPR40/FFAR1 agonist, in combination with metformin prevents progression of diabetes and β-cell dysfunction in Zucker diabetic fatty rats.
Ito R; Tsujihata Y; Matsuda-Nagasumi K; Mori I; Negoro N; Takeuchi K
Br J Pharmacol; 2013 Oct; 170(3):568-80. PubMed ID: 23848179
[TBL] [Abstract][Full Text] [Related]
11. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
12. Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide.
Alemzadeh R; Tushaus KM
Endocrinology; 2004 Dec; 145(12):5476-84. PubMed ID: 15319354
[TBL] [Abstract][Full Text] [Related]
13. Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model.
Piccolo BD; Graham JL; Stanhope KL; Fiehn O; Havel PJ; Adams SH
Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E958-69. PubMed ID: 27094034
[TBL] [Abstract][Full Text] [Related]
14. Chronic high-fat diet in fathers programs β-cell dysfunction in female rat offspring.
Ng SF; Lin RC; Laybutt DR; Barres R; Owens JA; Morris MJ
Nature; 2010 Oct; 467(7318):963-6. PubMed ID: 20962845
[TBL] [Abstract][Full Text] [Related]
15. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats.
Cummings BP; Bettaieb A; Graham JL; Stanhope KL; Dill R; Morton GJ; Haj FG; Havel PJ
Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14670-5. PubMed ID: 21873226
[TBL] [Abstract][Full Text] [Related]
17. Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".
Banerji MA
J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():493-501. PubMed ID: 12017222
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic fat content is associated with β-cell function and insulin resistance in Chinese type 2 diabetes subjects.
Lu T; Wang Y; Dou T; Xue B; Tan Y; Yang J
Endocr J; 2019 Mar; 66(3):265-270. PubMed ID: 30700664
[TBL] [Abstract][Full Text] [Related]
19. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Impact of Different Hypercaloric Diets on Weight Gain, Insulin Resistance, Glucose Intolerance, and its Comorbidities in Rats.
Melo BF; Sacramento JF; Ribeiro MJ; Prego CS; Correia MC; Coelho JC; Cunha-Guimaraes JP; Rodrigues T; Martins IB; Guarino MP; Seiça RM; Matafome P; Conde SV
Nutrients; 2019 May; 11(6):. PubMed ID: 31141900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
